0000939798-20-000007.txt : 20200604
0000939798-20-000007.hdr.sgml : 20200604
20200604171528
ACCESSION NUMBER: 0000939798-20-000007
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200602
FILED AS OF DATE: 20200604
DATE AS OF CHANGE: 20200604
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cataldo Tony
CENTRAL INDEX KEY: 0001450565
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-08092
FILM NUMBER: 20943709
MAIL ADDRESS:
STREET 1: C/O 475 INDUSTRIAL BLVD
CITY: WEST CHICAGO
STATE: IL
ZIP: 60106
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GT Biopharma, Inc.
CENTRAL INDEX KEY: 0000109657
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 941620407
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 310 N. WESTLAKE BLVD.
STREET 2: SUITE 206
CITY: WESTLAKE VILLAGE
STATE: CA
ZIP: 91362
BUSINESS PHONE: (800) 304-9888
MAIL ADDRESS:
STREET 1: 310 N. WESTLAKE BLVD.
STREET 2: SUITE 206
CITY: WESTLAKE VILLAGE
STATE: CA
ZIP: 91362
FORMER COMPANY:
FORMER CONFORMED NAME: OXIS INTERNATIONAL INC
DATE OF NAME CHANGE: 19940916
FORMER COMPANY:
FORMER CONFORMED NAME: DDI PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19920703
FORMER COMPANY:
FORMER CONFORMED NAME: DIAGNOSTIC DATA INC /DE/
DATE OF NAME CHANGE: 19850312
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2020-06-02
0
0000109657
GT Biopharma, Inc.
GTBP
0001450565
Cataldo Tony
9350 WILSHIRE BLVD.
SUITE 203
BEVERLY HILLS
CA
90212
1
1
1
0
CEO
common stock
2020-06-02
4
S
0
4234320
0.001
D
6500000
D
The disposal of the 4,234,320 shares was made to satisfy obligations pursuant to the terms of a Stock Pledge Agreement signed on August 1, 2018.
/s/ Tony Cataldo
2020-06-04